Legal Representation
Attorney
Brian T. Jaenicke
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description |
|---|---|---|---|
| May 26, 2015 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| May 25, 2015 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Oct 21, 2014 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 26, 2014 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 26, 2014 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 6, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 19, 2014 | ALIE | A | ASSIGNED TO LIE |
| Jul 19, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jul 1, 2014 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jul 1, 2014 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jul 1, 2014 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jul 1, 2014 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jul 1, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 24, 2014 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 5, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 27, 2014 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "SPANZAR" has no meaning in a foreign language.
Classification
International Classes
005